World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
56370
World Ranking
4881
National Ranking
151

Overview

Carlo Salvarani is affiliated with the University of Modena and Reggio Emilia in Italy and has an extensive body of work primarily in the field of Medicine, with a strong focus on Rheumatology. Their research covers significant subfields including Pulmonary and Respiratory Medicine, Immunology, Pathology and Forensic Medicine, and Genetics.

Salvarani's main research topics include:

  • Vasculitis and related conditions
  • Systemic Sclerosis and Related Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Systemic Lupus Erythematosus Research
  • Psoriasis: Treatment and Pathogenesis
  • Otitis Media and Relapsing Polychondritis

Recent publications by Salvarani cover a range of subjects and have appeared in various recognized venues. Selected recent papers include:

  • "Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review," 2022, International Journal of Environmental Research and Public Health
  • "Uveitis and Other Ocular Complications Following COVID-19 Vaccination," 2021, Journal of Clinical Medicine
  • "Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows," 2020, Journal of Clinical Medicine
  • "Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting," 2020, Arthritis & Rheumatology
  • "Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation," 2020, Critical Care

Collaborations feature prominently in Salvarani's career, with frequent co-authors including:

  • Francesco Muratore
  • Federica Lumetti
  • Lorenzo Dagna
  • Chiara Marvisi
  • Dilia Giuggioli

Salvarani has published extensively in several journals, with a notable number of works appearing in:

  • Annals of the Rheumatic Diseases
  • Clinical and Experimental Rheumatology
  • Lara D. Veeken
  • Journal of Clinical Medicine
  • Expert Review of Clinical Immunology

In addition to journal articles, Salvarani has contributed to academic books, including a publication with Springer International Publishing titled Large and Medium Size Vessel and Single Organ Vasculitis released in 2021.

Best Publications

  • EULAR Recommendations for the management of primary small and medium vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • Trial of Tocilizumab in Giant-Cell Arteritis.

    John H Stone;Katie Tuckwell;Sophie Dimonaco;Micki Klearman

  • The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria

    F. Davatchi;S. Assaad-Khalil;K. T. Calamia;J. E. Crook

  • Polymyalgia rheumatica and giant-cell arteritis.

    Carlo Salvarani;Fabrizio Cantini;Luigi Boiardi;Gene G. Hunder

  • Tocilizumab in patients with severe COVID-19: a retrospective cohort study

    Giovanni Guaraldi;Marianna Meschiari;Alessandro Cozzi-Lepri;Jovana Milic

  • Polymyalgia rheumatica and giant-cell arteritis

    Carlo Salvarani;Fabrizio Cantini;Gene G Hunder

  • EULAR recommendations for the management of Behçet disease

    G Hatemi;A Silman;D Bang;B Bodaghi

  • Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

    Jurgen Sota;Antonella Insalaco;Rolando Cimaz;Maria Alessio

  • EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

    Christian Dejaco;Sofia Ramiro;Christina Duftner;Florent L Besson

  • 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

    Bernhard Hellmich;Ana Agueda;Sara Monti;Frank Buttgereit

  • EULAR recommendations for the management of large vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative†

    Bhaskar Dasgupta;Marco A. Cimmino;Hilal Maradit Kremers;Wolfgang A. Schmidt

  • 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Bhaskar Dasgupta;Marco A Cimmino;Hilal Maradit-Kremers;Wolfgang A Schmidt

  • Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

    Carlo Salvarani;Giovanni Dolci;Marco Massari;Domenico Franco Merlo

  • Primary central nervous system vasculitis: analysis of 101 patients.

    Carlo Salvarani;Robert D. Brown;Kenneth T. Calamia;Teresa J. H. Christianson

  • Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial

    Gary S. Hoffman;Maria C. Cid;Karen E. Rendt-Zagar;Peter A. Merkel

  • 2018 update of the EULAR recommendations for the management of Behçet’s syndrome

    Gulen Hatemi;Robin Christensen;Dongsik Bang;Bahram Bodaghi

  • Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

    A Calin;B A C Dijkmans;P Emery;M Hakala

  • 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

    Christian Dejaco;Yogesh P. Singh;Pablo Perel;Andrew Hutchings

  • Takayasu's arteritis: A study of 104 Italian patients

    M. Vanoli;E. Daina;C. Salvarani;M. G. Sabbadini

Frequent Co-Authors

Gene G. Hunder
Gene G. Hunder Mayo Clinic
Maria C. Cid
Maria C. Cid University of Barcelona
Robert D. Brown
Robert D. Brown Mayo Clinic
Leonardo Punzi
Leonardo Punzi University of Padua
Roberto Gerli
Roberto Gerli University of Perugia
Roberto Caporali
Roberto Caporali University of Milan
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
John Huston
John Huston Mayo Clinic
Fabiola Atzeni
Fabiola Atzeni University of Messina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open new doors for those interested in the medical field. Many students choose online programs for their flexibility and affordability, making it easier to balance work and study. Popular options include affordable medical billing and coding programs, which prepare graduates for administrative roles in the healthcare system. These positions are essential in ensuring hospitals and clinics run smoothly.

Nursing is another rewarding pathway. Those seeking advanced clinical positions might consider the cheapest np school online options, which can lead to careers as nurse practitioners. Meanwhile, individuals entering the field can begin with an online nursing school, combining foundational knowledge with hands-on practice.

For those aiming for leadership or research, online nursing doctoral programs offer a pathway to advanced opportunities without pausing your career. Each of these online degrees provides a unique entry point into healthcare, making it easier than ever to find the right fit for your professional goals.

Best Scientists Citing Carlo Salvarani

Trending Scientists